{"id":"https://openalex.org/W2012197805","doi":"https://doi.org/10.1586/erp.09.58","title":"Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction","display_name":"Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction","alternate_titles":[],"publication_year":2009,"publication_date":"2009-11-27","ids":{"openalex":"https://openalex.org/W2012197805","doi":"https://doi.org/10.1586/erp.09.58","mag":"2012197805","pmid":"https://pubmed.ncbi.nlm.nih.gov/19941434"},"language":"en","primary_location":{"id":"doi:10.1586/erp.09.58","doi":"https://doi.org/10.1586/erp.09.58","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erp.09.58","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics &amp; Outcomes Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012197805"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051855660","display_name":"Anna Valeta Coma","orcid":"https://orcid.org/0000-0002-4656-1669","observed_orcids":["https://orcid.org/0000-0002-4656-1669"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Coma","raw_affiliation_strings":["Pharmacist, Barcelona Health Region, Catalan Health Service, Esteve Terrades 30, 08023 Barcelona, Spain. acomaf@catsalut.cat"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacist, Barcelona Health Region, Catalan Health Service, Esteve Terrades 30, 08023 Barcelona, Spain. acomaf@catsalut.cat","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014828756","display_name":"Corinne Zara","orcid":"https://orcid.org/0000-0002-6831-2233","observed_orcids":["https://orcid.org/0000-0002-6831-2233"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corinne Zara","raw_affiliation_strings":["Pharmacy Director, Barcelona Health Region, Catalan Health Service, Esteve Terrades 30, 08023 Barcelona, Spain. czara@catsalut.cat"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Director, Barcelona Health Region, Catalan Health Service, Esteve Terrades 30, 08023 Barcelona, Spain. czara@catsalut.cat","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100656935","display_name":"Brian Godman","orcid":"https://orcid.org/0000-0001-6539-6972","observed_orcids":["https://orcid.org/0000-0001-6539-6972"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["GB","IT","SE"],"is_corresponding":false,"raw_author_name":"Brian Godman","raw_affiliation_strings":["Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK and Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden and Institute for Pharmacological Research \u2018Mario Negri\u2019, Milan, Italy. godman@marionegri.it","Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK and Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden and Institute for Pharmacological Research \u2018Mario Negri\u2019, Milan, Italy. godman@marionegri.it","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I146655781","https://openalex.org/I19630809","https://openalex.org/I28166907"]},{"raw_affiliation_string":"Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859524","display_name":"Ant\u00f2nia Agust\u00ed","orcid":"https://orcid.org/0000-0003-4594-1122","observed_orcids":["https://orcid.org/0000-0003-4594-1122"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ant\u00f2nia Agust\u00ed","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia, Clinical Pharmacology Service, Vall d\u2019Hebron University Hospital, Pharmacology and Therapeutics Department, Autonomous University of Barcelona, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Passeig Vall d\u2019Hebron 119-129 08035 Barcelona, Spain. ag@icf.uab.es","Universitat Aut\u00f2noma de Barcelona, Cerdanyola del Vall\u00e8s, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia, Clinical Pharmacology Service, Vall d\u2019Hebron University Hospital, Pharmacology and Therapeutics Department, Autonomous University of Barcelona, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Passeig Vall d\u2019Hebron 119-129 08035 Barcelona, Spain. ag@icf.uab.es","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Universitat Aut\u00f2noma de Barcelona, Cerdanyola del Vall\u00e8s, Spain","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112900438","display_name":"Eduardo Diog\u00e8ne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eduardo Diog\u00e8ne","raw_affiliation_strings":["Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia, Clinical Pharmacology Service, Vall d\u2019Hebron University Hospital, Pharmacology and Therapeutics Department, Autonomous University of Barcelona, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Passeig Vall d\u2019Hebron 119-129, 08035 Barcelona, Spain. ed@icf.uab.es","Universitat Aut\u00f2noma de Barcelona, Cerdanyola del Vall\u00e8s, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3 Institut Catal\u00e0 de Farmacologia, Clinical Pharmacology Service, Vall d\u2019Hebron University Hospital, Pharmacology and Therapeutics Department, Autonomous University of Barcelona, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Passeig Vall d\u2019Hebron 119-129, 08035 Barcelona, Spain. ed@icf.uab.es","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641"]},{"raw_affiliation_string":"Universitat Aut\u00f2noma de Barcelona, Cerdanyola del Vall\u00e8s, Spain","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023766989","display_name":"Bj\u00f6rn Wettermark","orcid":"https://orcid.org/0000-0003-0531-2516","observed_orcids":["https://orcid.org/0000-0003-0531-2516"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I2801939835","display_name":"Region Stockholm","ror":"https://ror.org/02zrae794","country_code":"SE","type":"government","lineage":["https://openalex.org/I2801939835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Wettermark","raw_affiliation_strings":["Regional Drug Experts L\u00c4KSAK, Department of Drug Management and Informatics, Stockholm County Council, Sweden and Centre for Pharmacoepidemiology, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. bjorn.wettermark@sll.se","Karolinska University Hospital, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regional Drug Experts L\u00c4KSAK, Department of Drug Management and Informatics, Stockholm County Council, Sweden and Centre for Pharmacoepidemiology, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden. bjorn.wettermark@sll.se","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I2801939835","https://openalex.org/I28166907"]},{"raw_affiliation_string":"Karolinska University Hospital, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033055745","display_name":"Alan R Haycox","orcid":"https://orcid.org/0000-0001-6659-4866","observed_orcids":["https://orcid.org/0000-0001-6659-4866"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Haycox","raw_affiliation_strings":["University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK. ahay@liv.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK. ahay@liv.ac.uk","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5252,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.82206406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"9","issue":"6","first_page":"569","last_page":"581"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13555","display_name":"Healthcare cost, quality, practices","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prescribing-efficiency","display_name":"prescribing efficiency","score":0.9359999895095825},{"id":"https://openalex.org/keywords/prescription-drug-use","display_name":"prescription drug use","score":0.5789999961853027},{"id":"https://openalex.org/keywords/pharmaceutical-expenditure","display_name":"pharmaceutical expenditure","score":0.6830000281333923},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.8050000071525574},{"id":"https://openalex.org/keywords/brand-name-drugs","display_name":"brand-name drugs","score":0.859000027179718},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.9929999709129333},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9240000247955322},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.531000018119812},{"id":"https://openalex.org/keywords/catalonia","display_name":"Catalonia","score":0.4359999895095825},{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.4009999930858612},{"id":"https://openalex.org/keywords/defined-daily-doses","display_name":"defined daily doses","score":0.6050000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6058605313301086},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6056564450263977},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5782702565193176},{"id":"https://openalex.org/C2776865356","wikidata":"https://www.wikidata.org/wiki/Q1182681","display_name":"Defined daily dose","level":3,"score":0.4669996500015259},{"id":"https://openalex.org/C2778657065","wikidata":"https://www.wikidata.org/wiki/Q417997","display_name":"Ezetimibe","level":3,"score":0.43640998005867004},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.4206860661506653},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.3521423935890198},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21408137679100037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1586437225341797},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.13502487540245056},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.09304758906364441}],"mesh":[{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007356","descriptor_name":"Insurance, Pharmaceutical Services","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D012051","descriptor_name":"Reimbursement Mechanisms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/erp.09.58","doi":"https://doi.org/10.1586/erp.09.58","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erp.09.58","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics &amp; Outcomes Research","raw_type":"journal-article"},{"id":"pmid:19941434","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19941434","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324119","display_name":"Uppsala Universitet","ror":"https://ror.org/048a87296"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W148072","https://openalex.org/W16884164","https://openalex.org/W1486606675","https://openalex.org/W1502524639","https://openalex.org/W1525863247","https://openalex.org/W1594644684","https://openalex.org/W1981137843","https://openalex.org/W1984850666","https://openalex.org/W1988687175","https://openalex.org/W1990648978","https://openalex.org/W1995856335","https://openalex.org/W2023695089","https://openalex.org/W2024684933","https://openalex.org/W2034447052","https://openalex.org/W2036861336","https://openalex.org/W2039177190","https://openalex.org/W2042875425","https://openalex.org/W2043935608","https://openalex.org/W2057881392","https://openalex.org/W2059793614","https://openalex.org/W2061803932","https://openalex.org/W2072946225","https://openalex.org/W2074875954","https://openalex.org/W2083466115","https://openalex.org/W2086185330","https://openalex.org/W2111524839","https://openalex.org/W2114271048","https://openalex.org/W2120289695","https://openalex.org/W2132422694","https://openalex.org/W2134726862","https://openalex.org/W2137672274","https://openalex.org/W2138255900","https://openalex.org/W2154067841","https://openalex.org/W2167359851","https://openalex.org/W2168691997","https://openalex.org/W2169083980","https://openalex.org/W2219298356","https://openalex.org/W2727806123","https://openalex.org/W2995706065","https://openalex.org/W3124569675"],"related_works":["https://openalex.org/W1999805762","https://openalex.org/W2111321650","https://openalex.org/W2008860268","https://openalex.org/W2083466115","https://openalex.org/W3001775908","https://openalex.org/W2068049040","https://openalex.org/W2152453695","https://openalex.org/W2113798784","https://openalex.org/W2801318107","https://openalex.org/W2086951065"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"assess":[2],"the":[3,12,76,99,114,130,145,194,202,249],"impact":[4],"of":[5,16,44,93,107,129,147,159,187,253],"recent":[6],"national":[7],"and":[8,14,30,32,66,73,95,149,161,166,207,220,251,256],"regional":[9],"initiatives":[10,258],"on":[11],"utilization":[13,92,106,128,186],"expenditure":[15,200],"four":[17],"high-volume":[18],"classes":[19],"to":[20,56,197,224,241,246],"provide":[21,222],"future":[22],"guidance.":[23],"These":[24,173],"were":[25,117,141,164,175],"proton":[26,131,203],"pump":[27,132,204],"inhibitors,":[28,133,205],"statins":[29,94,206],"ezetimibe,":[31],"renin-angiotensin":[33,96],"drugs,":[34],"as":[35,37,79,81,102,104],"well":[36,80,103],"newer":[38,208],"antidepressants.":[39],"METHODS:":[40],"An":[41],"observational":[42],"study":[43,77,100],"prescriptions":[45],"dispensed":[46],"in":[47,50,111,144,152,181,216],"ambulatory":[48],"care":[49],"Catalonia":[51,240],"was":[52,59,90,125],"conducted":[53],"from":[54,243],"2003":[55,170],"2007.":[57],"Utilization":[58],"converted":[60],"into":[61],"defined":[62],"daily":[63],"doses":[64],"(DDDs)":[65],"DDDs":[67],"per":[68,71],"1000":[69],"inhabitants":[70],"day,":[72],"compared":[74],"over":[75,210],"period,":[78,101],"with":[82,190,218,230],"other":[83,225,244],"European":[84,226],"countries.":[85],"RESULTS:":[86],"As":[87],"expected,":[88],"there":[89],"increasing":[91],"drugs":[97],"during":[98],"increased":[105,127,185],"generics":[108,148],"versus":[109,154],"originators":[110],"each":[112],"class;":[113],"latter":[115],"figures":[116],"substantially":[118],"greater":[119,177],"than":[120,178],"those":[121,179,229],"published":[122],"previously.":[123],"There":[124,140,235],"also":[126],"which":[134],"is":[135,236],"a":[136],"cause":[137],"for":[138,193,201,233,239],"concern.":[139],"substantial":[142],"reductions":[143,174],"expenditure/DDDs":[146,158,192],"originator":[150,162,171],"products":[151],"2007":[153],"2003.":[155],"For":[156],"instance,":[157],"generic":[160],"simvastatin":[163],"81":[165],"72%,":[167],"respectively,":[168],"below":[169],"prices.":[172],"much":[176],"seen":[180],"previous":[182],"publications.":[183],"The":[184,213],"generics,":[188],"coupled":[189],"lower":[191],"classes,":[195],"led":[196],"reduced":[198],"reimbursed":[199],"antidepressants":[209],"time.":[211],"CONCLUSION:":[212],"findings":[214],"are":[215,259],"line":[217],"expectations":[219],"do":[221],"direction":[223],"countries,":[227],"especially":[228],"higher":[231],"expenditures/DDDs":[232],"generics.":[234],"an":[237],"opportunity":[238],"learn":[242],"countries":[245],"further":[247],"enhance":[248],"quality":[250],"efficiency":[252],"its":[254],"prescribing,":[255],"possible":[257],"discussed.":[260]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012197805","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
